Celgene Corp /De/ Insider Trades

Insider Trading History

Track insider trading activity for Celgene Corp /De/. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
10% owner
Holding Value $0 0 shares
Last Trade
Jul 09, 2020 Sale (In The Money)Reported as In The Money on SEC Form 4.
$2.27M 38,979 shares
$58.11
$57.13
Acceleron Pharma
Acceleron Pharma XLRN
10% owner
Holding Value $1.25B 7,010,751 shares
Last Trade
Jul 09, 2020 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$3.92M 38,979 shares
$100.68
$178.75
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
10% owner
Holding Value $401M 7,010,751 shares
Last Trade
Jul 09, 2020 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$2.27M 38,979 shares
$58.11
$57.13
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
10% owner
Holding Value $400M 7,008,510 shares
Last Trade
Jul 09, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$130k 2,241 shares
$58.11
$57.13
Acceleron Pharma
Acceleron Pharma XLRN
10% owner
Holding Value $1.25B 7,008,510 shares
Last Trade
Jul 09, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$229k 2,241 shares
$102.28
$178.75
Acceleron Pharma
Acceleron Pharma XLRN
10% owner
Holding Value $0 0 shares
Last Trade
Jul 09, 2020 Sale (In The Money)Reported as In The Money on SEC Form 4.
$3.92M 38,979 shares
$100.68
$178.75
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
10% owner
Holding Value $398M 6,971,772 shares
Last Trade
Jul 01, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.42M 108,108 shares
$59.43
$57.13
Acceleron Pharma
Acceleron Pharma XLRN
10% owner
Holding Value $1.25B 6,971,772 shares
Last Trade
Jul 01, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10M 108,108 shares
$92.50
$178.75
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
10% owner
Holding Value $52.4M 1,777,824 shares
Last Trade
Nov 12, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.5M 403,225 shares
$31.00
$29.46
Acceleron Pharma
Acceleron Pharma XLRN
10% owner
Holding Value $1.22B 6,824,685 shares
Last Trade
Jan 18, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.4M 706,206 shares
$43.00
$178.75
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
10% owner
Holding Value $208M 4,173,019 shares
Last Trade
Nov 21, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.8M 80,000 shares
$35.06
$49.80
Sutro Biopharma
Sutro Biopharma STRO
10% owner
Holding Value $49.7M 1,726,197 shares
Last Trade
Oct 01, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$25.3M 1,726,197 shares
$14.65
$28.80
Sutro Biopharma
Sutro Biopharma STRO
10% owner
Holding Value $0 0 shares
Last Trade
Sep 26, 2018 Sale
No data
No data
$28.80
Sutro Biopharma
Sutro Biopharma STRO
10% owner
Holding Value $0 0 shares
Last Trade
Sep 26, 2018 Sale
No data
No data
$28.80
Sutro Biopharma
Sutro Biopharma STRO
10% owner
Holding Value $0 0 shares
Last Trade
Sep 26, 2018 Sale
No data
No data
$28.80
Sutro Biopharma
Sutro Biopharma STRO
10% owner
Holding Value $0 0 shares
Last Trade
Sep 26, 2018 Sale
No data
No data
$28.80
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
10% owner
Holding Value $40.5M 1,374,599 shares
Last Trade
Jan 23, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$67.4M 851,154 shares
$79.20
$29.46
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
10% owner
Holding Value $40.5M 1,374,599 shares
Last Trade
Jan 23, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$67.4M 851,154 shares
$79.20
$29.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
10% owner
Holding Value $185M 3,722,534 shares
Last Trade
Dec 04, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$594k 30,485 shares
$19.47
$49.80
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
10% owner
Holding Value $187M 3,753,019 shares
Last Trade
Dec 01, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.68M 87,991 shares
$19.10
$49.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up